Why do GPs continue inappropriate hospital prescriptions of proton pump inhibitors? A qualitative study

European Journal of General Practice

Volumn 20, Issue 3, 2014, Pages 174-180

  Wermeling, Matthias ^a   Himmel, Wolfgang ^a   Behrens, Gesa ^a   Ahrens, Dirk ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

General practice; Qualitative design and methods; Quality of care

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARTICLE; CLINICAL EFFECTIVENESS; DRUG USE; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HUMAN; INAPPROPRIATE PRESCRIBING; MALE; NORMAL HUMAN; PERSONAL EXPERIENCE; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; PROFESSIONAL COMPETENCE; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; ATTITUDE TO HEALTH; CLINICAL COMPETENCE; CLINICAL PRACTICE; HEALTH PERSONNEL ATTITUDE; HOSPITAL; INTERVIEW; PHYSICIAN; PRIMARY HEALTH CARE; STANDARDS; STATISTICS AND NUMERICAL DATA;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; FEMALE; GENERAL PRACTITIONERS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALS; HUMANS; INAPPROPRIATE PRESCRIBING; INTERVIEWS AS TOPIC; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRIMARY HEALTH CARE; PROTON PUMP INHIBITORS;

EID: 84907356137     PISSN: 13814788     EISSN: 17511402     Source Type: Journal    
DOI: 10.3109/13814788.2013.844787     Document Type: Article

References (32)

1. Dorward. S, Sreedharan A, Leontiadis GI, Howden CW, Moayyedi P, Forman D. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2006; CD005415.
2. Galmiche J P, Letessier E, Scarpignato C. T reatment of gastro-oesophageal refl ux disease in adults. Br Med J. 1998; 316: 1720-3.
3. Moayyedi P, Talley NJ. Gastro-oesophageal refl ux disease. Lancet 2006; 367: 2086-100.
4. Leontiadis G I, McIntyre L, Sharma V K, Howden C W. P roton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2004; CD002094.
5. Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess. 2007; 11: iii-iv, 1-164.
6. Kandulski A, Selgrad M, Malfertheiner P. H elicobacter pylori infection: A clinical overview. Dig Liver Dis. 2008; 40: 619-26.
7. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-infl ammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010; 24: 121-32.
8. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. Br Med J. 2008; 336: 2-3.
9. Mössner J. Gastrointestinal drugs and laxatives [Magen- Darm-Mittel und Laxantien]. In: Schwabe U, Pfaffrath D, eds. Drug prescription report 2011 [Arzneiverordnungsreport 2011]. Berlin, Heidelberg, New York: Springer; 2011. pp. 681- 709.
10. Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. Br Med J. 1998; 317: 452-6.
11. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000; 25: 333-40.
12. Walker NM, McDonald J. An evaluation of the use of proton pump inhibitors. Pharm World Sci. 2001; 23: 116-7.
13. Gardner TB, Robertson DJ. Stress ulcer prophylaxis in noncritically ill patients: Less may be more. Am J Gastroenterol. 2006; 101: 2206-8.
14. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006; 101: 2200-5.
15. Molloy D, Molloy A, O' Loughlin C, Falconer M, Hennessy M. Inappropriate use of proton pump inhibitors. Ir J Med Sci. 2010; 179: 73-5.
16. van Vliet EP, Otten HJ, Rudolphus A, Knoester PD, Hoogsteden HC, Kuipers EJ, et al. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. Eur J Gastroenterol Hepatol. 2008; 20: 608-12.
17. Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: A 1-month survey. Aliment Pharmacol Ther. 2003; 17: 1503-6.
18. Grimmsmann T, Schwabe U, Himmel W. The infl uence of hospitalisation on drug prescription in primary care - a large-scale follow-up study. Eur J Clin Pharmacol. 2007; 63: 783-90.
19. Laheij R J, Sturkenboom M C, Hassing R J, Dieleman J, Stricker B H, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. J Am Med Assoc. 2004; 292: 1955-60.
20. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. J Am Med Assoc. 2006; 296: 2947-53.
21. Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficileassociated disease defined by prescription for oral vancomycin therapy. Can Med Assoc J. 2006; 175: 745-8.
22. Roth-Isigkeit A, Harder S. M edication in discharge letters [Die Entlassungsmedikation im Arztbrief]. Med Klin. 2005; 100: 87-93.
23. Ahrens D, Chenot JF, Behrens G, Grimmsmann T, Kochen MM. Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur J Clin Pharmacol. 2010; 66: 1265-71.
24. Ahrens D, Behrens G, Himmel W, Kochen M, Chenot JF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract. 2012; 66: 767-73.
25. Ritchie. J, Spencer L. Qualitative data analysis for applied policy research. In: Brymann A, Burgess R, editors. Analysing qualitative data. London: Routledge; 1994. pp. 173-94.
26. Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: perspectives of patients and their GPs. Br J Gen Pract. 2001; 51: 703-11.
27. Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): Patient self-regulation of treatment may be an under-exploited resource. Soc Sci Med. 2000; 51: 1827-39.
28. Dubois RW, Melmed GY, Henning JM, Laine L. Guidelines for the appropriate use of non-steroidal anti-infl ammatory drugs, cyclooxygenase- 2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-infl ammatory therapy. Aliment Pharmacol Ther. 2004; 19: 197-208.
29. Jaye C, Tilyard M. A qualitative comparative investigation of variation in general practitioners' prescribing patterns. Br J Gen Pract. 2002; 52: 381-6.
30. Lewis PJ, Tully MP. The discomfort of an evidence-based prescribing decision. J Eval Clin Pract. 2009; 15: 1152-8.
31. Lewis P J, Tully M P. U ncomfortable prescribing decisions in hospitals: The impact of teamwork. J R Soc Med. 2009; 102: 481-8.
32. Yachimski PS, Farrell EA, Hunt DP, Reid AE. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice. Arch Intern Med. 2010; 170: 779-83.